Inventiva (IVA) Total Non-Current Liabilities (2018 - 2025)

Inventiva (IVA) recorded quarterly Total Non-Current Liabilities of $233.6 million in Q4 2025, down 99.84% quarter-over-quarter from $146.5 billion in Q2 2025, and up 108.4% on a YoY basis from $112.1 million in Q4 2024.

Inventiva (IVA) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends

Inventiva's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $233.6 million for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities rose 108.4% year-over-year to $233.6 million; the TTM figure through Dec 2025 stood at $233.6 million (up 108.4% YoY), while the FY2025 annual figure was $233.6 million, up 108.4% from the prior year.
  • Total Non-Current Liabilities was $233.6 million for Q4 2025 at Inventiva, down from $146.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $146.5 billion in Q2 2025 to a low of $11.7 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $18.1 billion across 5 years, with a median of $55.3 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Total Non-Current Liabilities dropped 28.62% in 2021, then surged 93614.43% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $11.7 million in 2021, then jumped by 245.99% to $40.6 million in 2022, then surged by 36.19% to $55.3 million in 2023, then jumped by 102.53% to $112.1 million in 2024, then surged by 108.4% to $233.6 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $233.6 million (Q4 2025), $146.5 billion (Q2 2025), and $112.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 42,980.09
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 11.03 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 5.87 Bn
9 Abivax 95.45 Bn 95.45 Bn - 64.76 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 233.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 233.57 Mn
Jun 30, 2025 146.48 Bn
Dec 31, 2024 112.08 Mn
Dec 31, 2023 55.34 Mn
Dec 31, 2022 40.63 Mn
Jun 30, 2022 15.60 Bn
Dec 31, 2021 11.74 Mn
Jun 30, 2021 16.65 Mn
Mar 31, 2021 16.76 Mn
Dec 31, 2020 16.45 Mn
Jun 30, 2020 1.97 Mn
Dec 31, 2019 1.89 Mn
Dec 31, 2018 3.58 Mn